| Product Code: ETC11389294 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Anticoagulants Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Anticoagulants Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Anticoagulants Market - Industry Life Cycle |
3.4 Taiwan Anticoagulants Market - Porter's Five Forces |
3.5 Taiwan Anticoagulants Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Taiwan Anticoagulants Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Taiwan Anticoagulants Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Taiwan Anticoagulants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Taiwan |
4.2.2 Growing geriatric population in Taiwan |
4.2.3 Rising awareness about the importance of anticoagulant therapy in preventing stroke and other thrombotic events |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of anticoagulant drugs in Taiwan |
4.3.2 Limited access to advanced healthcare facilities in rural areas of Taiwan |
4.3.3 High cost associated with anticoagulant therapy leading to affordability issues for some patients |
5 Taiwan Anticoagulants Market Trends |
6 Taiwan Anticoagulants Market, By Types |
6.1 Taiwan Anticoagulants Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Anticoagulants Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Taiwan Anticoagulants Market Revenues & Volume, By Direct Oral Anticoagulants, 2021 - 2031F |
6.1.4 Taiwan Anticoagulants Market Revenues & Volume, By Vitamin K Antagonists, 2021 - 2031F |
6.1.5 Taiwan Anticoagulants Market Revenues & Volume, By Heparin, 2021 - 2031F |
6.2 Taiwan Anticoagulants Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Anticoagulants Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Taiwan Anticoagulants Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Taiwan Anticoagulants Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Anticoagulants Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.3.3 Taiwan Anticoagulants Market Revenues & Volume, By Atrial Fibrillation, 2021 - 2031F |
6.3.4 Taiwan Anticoagulants Market Revenues & Volume, By Pulmonary Embolism, 2021 - 2031F |
7 Taiwan Anticoagulants Market Import-Export Trade Statistics |
7.1 Taiwan Anticoagulants Market Export to Major Countries |
7.2 Taiwan Anticoagulants Market Imports from Major Countries |
8 Taiwan Anticoagulants Market Key Performance Indicators |
8.1 Number of new anticoagulant drug approvals by regulatory authorities in Taiwan |
8.2 Percentage increase in the adoption rate of anticoagulant therapy among the elderly population |
8.3 Rate of adherence to anticoagulant treatment guidelines by healthcare providers in Taiwan |
9 Taiwan Anticoagulants Market - Opportunity Assessment |
9.1 Taiwan Anticoagulants Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Taiwan Anticoagulants Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Taiwan Anticoagulants Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Taiwan Anticoagulants Market - Competitive Landscape |
10.1 Taiwan Anticoagulants Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Anticoagulants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here